Evidence map›Paper›PMID 24478060›Full record

ArticlePathogens and disease2014

Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.

David F Ackart, Laurel Hascall-Dove, Silvia M Caceres, Natalie M Kirk, Brendan K Podell, Christian Melander, Ian M Orme, Jeff G Leid, Jerry A Nick, Randall J Basaraba

Abstract read
In one paragraph

Article in Pathogens and disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Critical reviews in microbiology · 2026
    Review
  3. Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  4. Current topics in medicinal chemistry · 2026
    Article
  5. Article
  6. P3MA: A Promising Mycobacteriophage InfectingAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. ImmunoTargets and therapy · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David F AckartDepartment of Microbiology, Immunology and Pathology, Mycobacterial Research Laboratories, Colorado State University, Fort Collins, CO, USA.
Laurel Hascall-Dove
Silvia M Caceres
Natalie M Kirk
Brendan K Podell
Christian Melander
Ian M Orme
Jeff G Leid
Jerry A Nick
Randall J Basaraba

Funding

Response Therapies for MDR-TBU01AI070456 · NIAID · COLORADO STATE UNIVERSITY · PI ORME, IAN M · 2006 to 2010
$6.4M
Biomedical Research Training for VeterinariansT32OD010437 · OD · COLORADO STATE UNIVERSITY · PI Gregg A Dean, KELLY S SANTANGELO · 2012 to 2026
$6.2M
Disrupting Biofilm Formation to Improve TB Drug TreatmentR01AI106733 · NIAID · COLORADO STATE UNIVERSITY · PI BASARABA, RANDALL J · 2013 to 2017
$2.3M
Viral-induced Adaptation of Neutrophil Response in ARDSR01HL090991 · NHLBI · NATIONAL JEWISH HEALTH · PI NICK, JERRY A · 2007 to 2010
$1.7M
Prevention of oxidative stress decreases persistence of drug tolerant M. TubercuR21AI083856 · NIAID · COLORADO STATE UNIVERSITY · PI BASARABA, RANDALL J · 2009 to 2010
$399k
NHLBI NIH HHS 1R01HL090991NHLBI NIH HHS R01 HL090991NIAID NIH HHS 1R01AI106733NIAID NIH HHS AI070456NIAID NIH HHS AI083856NIAID NIH HHS R01 AI106733NIAID NIH HHS R21 AI083856NIAID NIH HHS U01 AI070456NIH HHS T32 OD010437
6 · The paper itself

Abstract

There is an urgent need to improve methods used to screen antituberculosis drugs. An in vitro assay was developed to test drug treatment strategies that specifically target drug-tolerant Mycobacterium tuberculosis. The H37Rv strain of M. tuberculosis survived antimicrobial treatment as attached microbial communities when maintained in tissue culture media (RPMI-1640) with or without lysed human peripheral blood leukocytes. When cultured planktonically in the presence of Tween-80, bacilli failed to form microbial communities or reach logarithmic phase growth yet remained highly susceptible to antimicrobial drugs. In the absence of Tween, bacilli tolerated drug therapy by forming complex microbial communities attached to untreated well surfaces or to the extracellular matrix derived from lysed human leukocytes. Treatment of microbial communities with DNase I or Tween effectively dispersed bacilli and restored drug susceptibility. These data demonstrate that in vitro expression of drug tolerance by M. tuberculosis is linked to the establishment of attached microbial communities and that dispersion of bacilli targeting the extracellular matrix including DNA restores drug susceptibility. Modifications of this in vitro assay may prove beneficial in a high-throughput platform to screen new antituberculosis drugs especially those that target drug-tolerant bacilli.

Indexed as

Antitubercular AgentsBiofilmsCulture MediaDeoxyribonuclease IDrug Resistance, BacterialGene Expression Regulation, BacterialHumansIsoniazidMicrobial Sensitivity TestsMycobacterium tuberculosisPolysorbatesRifampinAntitubercular AgentsCulture MediaDeoxyribonuclease IIsoniazidPolysorbatesRifampinbiofilmdrug resistantdrug tolerantmicrobial communitiesMycobacterium tuberculosis

Identifiers

PMID24478060
PMCPMC4361083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.